SLC1A5 overexpression accelerates progression of hepatocellular carcinoma by promoting M2 polarization of macrophages.
10.12122/j.issn.1673-4254.2025.02.08
- Author:
Jinhua ZOU
1
;
Hui WANG
1
;
Dongyan ZHANG
1
Author Information
1. Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- Publication Type:Journal Article
- Keywords:
M2 macrophages;
SLC1A5;
hepatocellular carcinoma;
pan-cancer;
proliferation
- MeSH:
Humans;
Carcinoma, Hepatocellular/metabolism*;
Liver Neoplasms/metabolism*;
Animals;
Macrophages/cytology*;
Disease Progression;
Cell Line, Tumor;
Mice;
Amino Acid Transport System ASC/genetics*;
Cell Proliferation;
Lymphatic Metastasis;
Mice, Nude;
Prognosis;
Minor Histocompatibility Antigens
- From:
Journal of Southern Medical University
2025;45(2):269-284
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the clinical significance of SLC1A5 overexpression in pan-cancer and its mechanism for promoting hepatocellular carcinoma (HCC) progression.
METHODS:We analyzed the correlation of SLC1A5 expression with clinical stage, lymph node metastasis and prognosis in pan-cancer using TCGA and ICGC datasets and explored its association with immune cell infiltration using EPIC, CIBERSORT, and TIMER algorithms. In HCC cell lines, the effects of lentivirus-mediated SLC1A5 overexpression or RNA interference on cell proliferation were examined using CCK-8 assay, and the growth of HCC cell xenografts overexpressing SLC1A5 was observed in nude mice. The effects of SLC1A5 overexpression or silencing in HCC cells on macrophage polarization were evaluated in a cell co-culture system.
RESULTS:SLC1A5 was mainly localized on cell membrane and was highly expressed in most cancers in association with clinical stage, lymph node metastasis and poor prognosis. SLC1A5 expression was positively correlated with immunity score in 13 cancer types, especially in low-grade glioma (LGG), LIHC and thyroid cancer. SLC1A5 was positively correlated with macrophage infiltration level in LGG and LIHC but negatively correlated with macrophage infiltration in 5 cancers including lung squamous carcinoma, pancreatic carcinoma, and gastric carcinoma. Patients with SLC1A5 overexpression and high level of M2 macrophage infiltration had the worst survival outcomes. SLC1A5 was correlated with immunosuppression-related genes, cytokines, and cytokine receptors, which was the most obvious in LGG and LIHC. SLC1A5 was highly expressed in different HCC cell lines, and its overexpression promoted HCC cell proliferation both in vitro and in nude mice. In the cell co-culture experiment, SLC1A5 was positively correlated with the molecular markers of M2 polarization of macrophages, and its overexpression strongly promoted M2 polarization of the macrophages and inhibited T cell secretion of IFN-γ.
CONCLUSIONS:SLC1A5 expression level is correlated with clinical stage, lymph node metastasis, prognosis, and immune cell infiltration in most cancers, and its overexpression promotes HCC progression by inhibiting T-cell function via promoting M2 polarization of macrophages.
